Skip to main content

Silo Pharma, Inc.

For the period ended Aug 14, 2026. Filed Jun 30, 2026.

View on SEC.gov

About this filing

What shareholders are asked to vote on at a company's meeting. It is where to find what directors and top executives are paid, and who owns the most shares.

Aug 14, 2026 · Filed Jun 30, 2026

SILO$1.33+3.1%Stored close · as of Nov 6, 2026
See the whole filing, with its images and exhibits
Contents

What is a proxy statement?

A proxy statement is a document that we are required by regulations of the U.S. Securities and Exchange Commission (“SEC”) to give you when we ask you to sign a proxy card designating Mr. Weisblum as proxy to vote on your behalf.

ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.